Vol. 141, No. 24 — June 16, 2007
Statutory authority
Food and Drugs Act
Sponsoring department
Department of Health
REGULATORY IMPACT ANALYSIS STATEMENT
For the Regulatory Impact Analysis Statement, see the Regulations Amending Certain Regulations Made under the Food and Drugs Act (Project 1539).
Notice is hereby given that the Governor in Council, pursuant to subsection 30(1) (see footnote a) of the Food and Drugs Act, proposes to make the annexed Regulations Amending Schedule A to the Food and Drugs Act and the Medical Devices Regulations (Project 1539).
Interested persons may make representations concerning the proposed Regulations within 75 days after the date of publication of this notice. All such representations must cite the Canada Gazette, Part I, and the date of publication of this notice, and be addressed to Project #1539, Policy Division, Bureau of Policy, Science, and International Programs, Therapeutic Products Directorate, 1600 Scott Street, Holland Cross, Tower B, 2nd floor, Address Locator 3102C5, Ottawa, Ontario K1A 0K9 (tel.: 613-948-4623; fax: 613-941-6458; e-mail: regaff-affreg@hc-sc.gc.ca), with a reference to Project #1539.
Ottawa, June 7, 2007
MARY O'NEILL
Assistant Clerk of the Privy Council
REGULATIONS AMENDING SCHEDULE A TO THE FOOD AND DRUGS ACT AND THE MEDICAL DEVICES REGULATIONS (PROJECT 1539)
FOOD AND DRUGS ACT
1. The references to
Alcoholism
Alcoolisme
Alopecia (except hereditary androgenetic alopecia)
Alopécie (sauf l'alopécie androgénogénétique)
Anxiety state
États d'angoisse
Arthritis
Arthrite
Bladder disease
Vessie (maladies)
Disease of the prostate
Prostate (maladies)
Disorder of menstrual flow
Troubles du flot menstruel
Dysentery
Dysenterie
Edematous state
Œdème
Epilepsy
Épilepsie
Gall bladder disease
Vésicule biliaire (maladies)
Gout
Goutte
Heart disease
Cœur (maladies)
Hernia
Hernie
Hypotension
Hypotension
Impetigo
Impétigo
Kidney disease
Reins (maladies)
Leukemia
Leucémie
Liver disease (except hepatitis)
Foie (maladies sauf l'hépatite)
Pleurisy
Pleurésie
Sexual impotence
Impuissance sexuelle
Tumor
Tumeurs
Venereal disease
Maladies vénériennes
in Schedule A to the Food and Drugs Act (see footnote 1) are repealed.
2. Schedule A to the Act is amended by adding the following in alphabetical order:
Acute alcoholism
Alcoolisme aigu
Acute anxiety state
État anxieux aigu
Acute infectious respiratory syndromes
Syndromes respiratoires infectieux aigus
Acute, inflammatory and debilitating arthritis
Arthrite aiguë, inflammatoire et débilitante
Acute psychotic conditions
Troubles psychotiques aigus
Addiction
Dépendance
Congestive heart failure
Insuffisance cardiaque congestive
Dementia
Démence
Haematologic bleeding disorders
Affections hématologiques hémorragiques
Hepatitis
Hépatite
Sexually transmitted diseases
Maladies transmises sexuellement
Strangulated hernia
Hernie étranglée
MEDICAL DEVICES REGULATIONS
3. Subsection 24(1) of the Medical Devices Regulations (see footnote 2) is replaced by the following:
24. (1) For the purposes of subsections 3(1) and (2) of the Act and subject to section 27, a condom may be advertised and sold to the general public for the purpose of preventing the transmission of sexually transmitted diseases if the advertisement and the label of the condom claim only that the condom reduces the risk of transmitting sexually transmitted diseases.
COMING INTO FORCE
4. These Regulations come into force on the day on which they are registered.
[24-1-o]
S.C. 1999, c. 33, s. 347
R.S., c. F-27
SOR/98-282
NOTICE:
The format of the electronic version of this issue of the Canada Gazette was modified in order to be compatible with extensible hypertext markup language (XHTML 1.0 Strict).